Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥1,908,000 | ¥4,218,000 | ¥5,076,000 | ¥6,720,000 |
| Dep. & Amort. | ¥4,332,000 | ¥3,659,000 | ¥3,870,000 | ¥3,313,000 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥540,000 | -¥1,174,000 | -¥2,326,000 | -¥4,399,000 |
| Other Non-Cash | ¥197,000 | -¥1,521,000 | -¥2,465,000 | -¥1,264,000 |
| Operating Cash Flow | ¥5,897,000 | ¥5,182,000 | ¥4,155,000 | ¥4,370,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥7,095,000 | -¥6,276,000 | -¥5,556,000 | -¥4,733,000 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥68,000 |
| Inv. Purchases | -¥713,000 | ¥0 | ¥0 | -¥68,000 |
| Inv. Sales/Matur. | ¥444,000 | ¥335,000 | ¥0 | ¥256,000 |
| Other Inv. Act. | -¥1,000 | ¥11,000 | -¥10,000 | ¥77,000 |
| Investing Cash Flow | -¥7,365,000 | -¥5,930,000 | -¥5,566,000 | -¥4,400,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥2,625,000 | ¥1,971,000 | ¥1,362,000 | ¥56,000 |
| Stock Issued | ¥0 | ¥0 | ¥308,000 | ¥1,514,000 |
| Stock Repurch. | -¥623,000 | -¥1,176,000 | -¥116,000 | ¥0 |
| Dividends Paid | -¥998,000 | -¥907,000 | -¥931,000 | -¥660,000 |
| Other Fin. Act. | -¥2,000 | -¥71,000 | -¥7,000 | ¥79,000 |
| Financing Cash Flow | ¥1,002,000 | -¥183,000 | ¥616,000 | ¥989,000 |
| Forex Effect | -¥54,000 | ¥51,000 | ¥20,000 | ¥48,000 |
| Net Chg. in Cash | -¥520,000 | -¥880,000 | -¥774,000 | ¥1,009,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥2,727,000 | ¥3,607,000 | ¥4,381,000 | ¥3,372,000 |
| End Cash | ¥2,207,000 | ¥2,727,000 | ¥3,607,000 | ¥4,381,000 |
| Free Cash Flow | -¥957,000 | -¥1,094,000 | -¥1,401,000 | -¥363,000 |